Results 201 to 210 of about 164,355 (372)

2783. Expansion of Monocytic Myeloid-Derived Suppressor Cells in Infants with Severe Respiratory Syncytial Virus (RSV) Infection [PDF]

, 2019
Santiago Acero Bedoya, Fang Ye, Victoria Best, Octavio Ramilo, Octavio Ramilo, Asunción Mejías   +5 more
openalex   +1 more source

Point‐of‐Care Testing by Multiplex‐PCR in Different Compartments in Suspected Lower Respiratory Tract Infection After Lung Transplantation—Results of a Prospective Study

Transplant Infectious Disease, EarlyView.
Use of POCtmPCR with noninvasive samples (NPS and sputum) in LTx recipients with viral LRTI are a viable alternative to invasive BAL sampling, ABSTRACT Background Respiratory tract infections (RTIs) are a leading cause of morbidity and mortality following lung transplantation (LTx).
Susanne Simon, Merle Sophie Kaiser, Marcus Bachmann, Gérard Krause, Jens Gottlieb   +4 more
wiley   +1 more source

Molecular Respiratory Pathogen Panels in Lung Transplantation

Transplant Infectious Disease, EarlyView.
ABSTRACT Molecular respiratory pathogen panels are an innovative tool for the rapid detection of respiratory pathogens and antimicrobial resistance genes, offering the potential to improve diagnostic accuracy and guide timely antimicrobial therapy.
Andrea Lombardi
wiley   +1 more source

European multicenter evaluation of Xpert® Xpress SARS‐CoV‐2/Flu/RSV test [PDF]

, 2021
Femke Wolters, Maria Grünberg, Michael Huber, Harald H. Kessler, Florian Prüller, Lanja Saleh, Christine Fébreau, Janette Rahamat–Langendoen, Vincent Thibault, Willem J. G. Melchers   +9 more
openalex   +1 more source

Epidemiology and Clinical Impact of Confirmed Respiratory Viral Infections in Solid Organ Transplant Recipients

Transplant Infectious Disease, EarlyView.
ABSTRACT Background Respiratory viral infections (RVIs) can have distinct clinical presentations and outcomes in non‐lung solid organ transplant (SOT) recipients compared to non‐transplant and lung transplant patients. Understanding their impact is crucial for improving patient care and outcomes.
Manon L. M. Prins, Ernst D. van Dokkum, Aiko P. J. de Vries, Maarten E. Tushuizen, Danny van der Helm, Edwin M. Spithoven, Irene M. van der Meer, Eduard M. Scholten, Albert M. Vollaard, Saskia le Cessie, Leo G. Visser, Geert H. Groeneveld   +11 more
wiley   +1 more source

RSV temporally reprograms apoptosis and pyroptosis to balance immune evasion and replication. [PDF]

Sci Adv
Liu C, Zhou H, Li J, Meng Y, Wang J, He M, Wang W, Li Z, Qin Y, Chen M.   +9 more
europepmc   +1 more source

Structural Mapping of Surveillance Data Reveals Conservation of NNI Binding Site in RSV L Protein [PDF]

Ruchin Patel, Edward Murray, Debbie Nahas, Mahdieh Yazdani, Brett R. Ambler, Nicholas Murgolo, John A. Howe   +6 more
openalex   +1 more source

Stewardship of Molecular Diagnostics in Transplant Viral Infections

Transplant Infectious Disease, EarlyView.
ABSTRACT The transplant environment requires special considerations when testing for viral infections as immunosuppression results in atypical infection profiles. Microbes otherwise considered commensals or causing mild disease can lead to severe infections in transplant environments. Therefore, guidelines tend to recommend broader microbial testing in
Scott Sugden, David Reynoso, Reema Mathew, Michael Loeffelholz   +3 more
wiley   +1 more source

Short-term and long-term risk of death and readmission among adults aged 50+ years admitted with severe acute respiratory infections due to COVID-19, influenza or RSV in Denmark, 2022-2025. [PDF]

BMJ Public Health
Lomholt FK, Soborg B, Valentiner-Branth P, Slotved HC, Fuursted K, Benfield T, Vestergaard LS.   +6 more
europepmc   +1 more source

Respiratory Syncytial Virus in Hematopoietic Cell Transplant Recipients: Clinical and Humoral Risk Factors for Infection. [PDF]

Open Forum Infect Dis
Pernikoff S, Clurman A, Rötepohl M, Galanter N, Bibby M, Harris E, Stevens-Ayers T, Xie H, Ueda Oshima M, Cheng GS, Englund JA, Boeckh MJ, Boonyaratanakornkit J.   +12 more
europepmc   +1 more source